Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study

Summary: Background: People with end-stage kidney disease, including people on haemodialysis, are susceptible to greater COVID-19 related morbidity and mortality. This study compares the immunogenicity and clinical effectiveness of BNT162B2 versus ChAdOx1 in haemodialysis patients. Methods: In this...

詳細記述

保存先:
書誌詳細
主要な著者: Paul Martin (著者), Sarah Gleeson (著者), Candice L. Clarke (著者), Tina Thomson (著者), Helena Edwards (著者), Katrina Spensley (著者), Paige Mortimer (著者), Stacey McIntyre (著者), Alison Cox (著者), Graham Pickard (著者), Liz Lightstone (著者), David Thomas (著者), Stephen P. McAdoo (著者), Peter Kelleher (著者), Maria Prendecki (著者), Michelle Willicombe (著者)
フォーマット: 図書
出版事項: Elsevier, 2022-10-01T00:00:00Z.
主題:
オンライン・アクセス:Connect to this object online.
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!